BioDuro
BioDuro-Sundia, an Advent International portfolio company, is a trusted, leading contract research, development, and manufacturing organization (CRDMO) with over 27 years of experience.
Description
BioDuro is a global Contract Research, Development, and Manufacturing Organisation (CRDMO) providing integrated solutions to accelerate drug discovery and development.
BioDuro is a technology-driven CRDMO committed to delivering innovative solutions that streamline the journey from early-stage drug discovery to commercial-scale manufacturing. With operations spanning the globe and a workforce of over 2,000 professionals, the company combines scientific expertise with state-of-the-art facilities to support its clients in creating transformative therapies.
Headquartered in San Diego, California, BioDuro operates multiple research and development centres in the United States and China, enabling seamless collaboration and cross-border integration. Its offerings include discovery, development, and manufacturing services for small molecules, peptides, and biopharmaceuticals, all underpinned by a client-centric approach that emphasises quality, flexibility, and speed.
Key Products and Services:
- Drug Discovery Services: Medicinal chemistry, biology, and integrated Drug Metabolism and Pharmacokinetics (DMPK) solutions.
- Peptide Development: Solid-phase and liquid-phase peptide synthesis, from early research to kilogram-scale manufacturing.
- Small Molecule Development: API synthesis, process development, and formulation.
- Biopharmaceutical Manufacturing: Cell-line development and biologics production.
- Integrated CRDMO Platform: End-to-end solutions covering discovery, development, and manufacturing.
BioDuro is dedicated to partnering with pharmaceutical and biotechnology companies to drive the development of innovative therapeutics. By combining advanced scientific expertise with cutting-edge technologies, the company ensures efficient and reliable delivery of high-quality solutions, empowering its clients to bring life-changing medicines to market faster.